CCKBR (Gastrin Receptor) as a Theranostic Target in Oncology: Biological Rationale, Diagnostic Imaging, and Next-Generation Peptide-Based Drug Development. [PDF]
Chang MC +4 more
europepmc +1 more source
Comparative Immunohistochemical Analysis of FAP and c-MET Expression Across Renal Cell Carcinoma Subtypes: Preliminary Results and Potential Theranostic Implications. [PDF]
Unterrainer LM +8 more
europepmc +1 more source
Multifunctional Hybrid Nanomedicines for Neurodegenerative Diseases: A Paradigm Shift from Rational Design to Clinical Translation. [PDF]
Wu Y +6 more
europepmc +1 more source
Comment on "Theranostic lipid nanocarriers for precision diagnosis and targeted therapy in pancreatic ductal adenocarcinoma". [PDF]
Khakimovna KA +2 more
europepmc +1 more source
Smart Theranostic Nanoplatforms in Oral Squamous Cell Carcinoma: Integrating Diagnosis, Targeted Therapy and Synergistic Photothermal/Photodynamic Approaches. [PDF]
Lucchesi Palli L +2 more
europepmc +1 more source
Peptide-nanoparticle conjugates as a theranostic platform
Theranostic platforms have emerged as advanced systems integrating diagnostic and therapeutic agents to enable personalized medicine tailored to the specific characteristics of each patient's disease.
Konstantin Konstantinov (1361943) +5 more
core
The next evolution of theranostics: from target discovery to integrated precision medicine. [PDF]
Montemagno C, Serrano B, Paulmier B.
europepmc +1 more source
Theranostic Nanoprobes for Rheumatoid Arthritis: From Inflammation Visualization to Guided Precision Therapy. [PDF]
Hao M, Zhu Y, Su Z, Liu X.
europepmc +1 more source
Radiopharmaceuticals and theranostics: reshaping cancer diagnosis and therapy with targeted radionuclides. [PDF]
Zulfiqar H, Waqas M, Ali I.
europepmc +1 more source
Carrier-Free Stimulus-Responsive Theranostic Nanoprodrug Enabling GSH-Consumption-Promoted Chemo-Photodynamic Cancer Therapy. [PDF]
Huang H, Sui B.
europepmc +1 more source

